Erdheim-Chester disease: a new international cohort study on phenotype, treatment, and determinants of prognosis
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Erdheim-Chester disease: a new international cohort study on phenotype, treatment, and determinants of prognosis
-
ナレーター：
-
著者：
Professor Julien Haroche and Professor Augusto Vaglio join us this month to discuss their new international cohort study describing phenotype, treatment, and determinants of prognosis in 1174 patients with Erdheim-Chester disease.
Click here to read the full article:
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00247-4/fulltext
The Lancet Haematology in conversation with... is part of the Lancet Group podcast offering.
Editorial team: editor-in-chief Lan-Lan Smith, deputy editor Emma Cookson, and senior editor Daniela Marin
Podcast editing: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at www.thelancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv